Investor Presentation Nov


Published on

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Continuous flow Allows for uninterrupted fluid disposal No disruption of procedure Ease of Use Touch screen operation Enhanced safety and efficiency Regulatory Compliance Allows hospitals to meet current regulatory standards “ green” Economical Average end-user saves $250,000 annually Greater OR scheduling flexibility Visibility of fluids Allows OR personnel to analyze fluid Continuous fluid volume measurement
  • Investor Presentation Nov

    1. 1. Kevin Davidson President & CEO
    2. 2. Operative Fluid Management <ul><li>The issues… </li></ul><ul><li>Safety </li></ul><ul><li>Cost </li></ul><ul><li>OR Efficiency </li></ul><ul><li>Regulatory Compliance </li></ul><ul><li>Environment </li></ul><ul><li>  </li></ul>
    3. 3. Operative Fluid Management <ul><li>The evolution…… </li></ul>and then what?
    4. 4. The STREAMWAY™ System Fully automated, wall mounted, for the safe suction, containment, measurement, visibility and disposal of operative fluids
    5. 5. <ul><ul><li>Filter used to keep instrument clear of debris </li></ul></ul><ul><ul><li>Fluid cleans unit after each use </li></ul></ul><ul><ul><ul><li>Removes all bacteria </li></ul></ul></ul><ul><ul><ul><li>Prevents formation of bio-films which can host viruses </li></ul></ul></ul><ul><ul><ul><li>Prevents cross-contamination </li></ul></ul></ul><ul><ul><ul><li>Biodegradable </li></ul></ul></ul><ul><ul><ul><li>“ Razor Blade” </li></ul></ul></ul><ul><ul><li>Fully automated, continuous suction system </li></ul></ul><ul><ul><li>Unlimited processing </li></ul></ul><ul><ul><li>Processes all fluids, tissue and bone chips </li></ul></ul><ul><ul><li>Visibility & measurement </li></ul></ul><ul><ul><li>Frees up OR floor space </li></ul></ul><ul><ul><li>Rapid OR turnaround time </li></ul></ul><ul><ul><li>“ Razor” </li></ul></ul>The STREAMWAY™ System Disposable Kit Filter / Cleaning Fluid Patented Instrument
    6. 6. Existing Disposal Process Start End End
    7. 7. STREAMWAY TM Disposal Process
    8. 8. U.S. Market Opportunity <ul><li>Patented Instrument </li></ul><ul><li>United States market has in excess of 40,000 (1) ORs and surgical centers </li></ul><ul><li>5% to 8% annual growth of new facilities (3) </li></ul><ul><li>Market opportunity exceeds $650 million </li></ul><ul><li>Disposable Kit </li></ul><ul><li>United States has approx. 50,000,000 hospital and ambulatory surgical procedures annually (2) </li></ul><ul><li>Market opportunity exceeds </li></ul><ul><li>$850 million </li></ul><ul><li>All data from AHA Hospital Statistics, 2008 edition </li></ul><ul><li>AIA Consensus Construction Forecast </li></ul>Total US Only market opportunity > $1,500,000,000
    9. 9. Competitive Overview <ul><li>Continuous flow </li></ul><ul><li>Fully automated </li></ul>( 1) The Cardinal Orwell system recent obtained FDA clearance it is expected to be on the market by Q4 2009 STREAMWAY System is “the” superior solution to operative fluid management <ul><li>Ultimate in compliance </li></ul><ul><li>Green solution </li></ul>Improves Regulatory Compliance Minimal Waste Disposal Fully Automated Self Cleaning Continuous Suction Environmentally Friendly STREAMWAY Yes Yes Yes Yes Yes Stryker Yes No No No No Dornoch Yes No No No No DeRoyal Yes No No No No Cardinal (1) Yes No No No No Bemis Yes No No No No MD Technologies Yes Yes No No Yes
    10. 10. Operative Fluid Management Regulatory Overview <ul><li>Enables compliance to state and federal regulations </li></ul><ul><ul><li>OSHA, EPA, DOT, CDC </li></ul></ul><ul><li>Reduces cost of infecting hospital staff </li></ul><ul><li>No requirement for a specialized handling/transportation department or hazardous materials compliance </li></ul>
    11. 11. BioDrain vs. The Canister Pouring BioDrain (1) (1) In addition, BioDrain creates OR efficiencies that could add significant revenue! WE IMPROVE HOSPITALS’ FINANCIALS! Cost Per OR - Per Year Solidifier Canisters and Lids $8,000 $8,000 $0 Solidifier $12,000 $0 $0 BioDrain System $0 $0 $17,000 Biohazard disposal costs $12,800 $1,600 $0 Processing Labor $17,500 $12,500 $2,500 Processing Consumables $5,000 $5,000 $0 Spill Costs $10,000 $30,000 $0 Filter / Cleaning Solution $0 $0 $15,000 Total Year 1 $65,300 $57,100 $34,500 Total Year 2 $65,300 $57,100 $17,500 2 Year Total $130,600 $114,200 $52,000
    12. 12. Short Term Milestones <ul><li>Secure patent - done </li></ul><ul><li>Produce 5 production-ready units - done </li></ul><ul><li>Complete UL/TUV testing - done </li></ul><ul><li>Submit FDA 510K - done </li></ul><ul><li>FDA approval – done </li></ul><ul><li>Product launch – done </li></ul><ul><li>Beta site installation – done </li></ul><ul><li>Pass FDA audit - done </li></ul><ul><li>Complete SEC registration – done </li></ul><ul><li>Establish distribution channel – 16 states covered </li></ul><ul><li>Secure additional financing – ~ $500 K bridge raised </li></ul><ul><li>Trade on OTCBB - pending </li></ul>
    13. 13. BioDrain Financial Forecast ($000) 2010 2011 2012 2013 2014 Sales Hardware 2,066 11,145 16,440 22,215 28,425 Disposables Service 1,390 7,841 21,082 39,636 63,943 Total 32 3,488 169 19,155 331 37,852 461 62,312 601 92,969 Gross Profit 1,753 11,410 24,488 43,176 65,141 Operating Income (1,738) 1,967 10,121 23,293 38,491 Net Income - After Tax (1,738) 1,180 6,072 13,976 23,094
    14. 14. Management <ul><li>Kevin Davidson, President & CEO, Director </li></ul><ul><ul><li>Mr. Davidson has over 20 years experience in the medical technology sector. He has been the CFO of three medical technology companies and as an investment banker led and closed several transactions in this sector. </li></ul></ul><ul><li>Chad Ruwe, COO, Director </li></ul><ul><ul><li>Mr. Ruwe has over 20 years experience in critical fluid management industries focused on containment, management, and delivery of highly toxic and corrosive fluids. Mr. Ruwe has extensive experience managing international joint ventures, wholly owned foreign entities and outsource manufacturing partners. </li></ul></ul><ul><li>Kirsten Doerfert, VP of Sales & Marketing </li></ul><ul><ul><li>Ms. Doerfert has a long history of medical technology sales and marketing successes, has been a senior-level executive in medical device companies and is a licensed nurse, which will improve communication with our OR customers. </li></ul></ul><ul><li>Alan Shuler, Acting CFO </li></ul><ul><ul><li>Mr. Shuler has over 30 years of financial experience. Mr. Shuler has been the CFO of publically traded companies, is SEC knowledgeable, provides Investor Relations expertise, and has lead and completed several funding efforts with several different entities. </li></ul></ul>
    15. 15. Board of Directors <ul><li>Larry Gadbaw </li></ul><ul><ul><li>Served as BioDrain President and CEO and Executive VP Business Development ● President and COO and Director of Augustine Medical, Inc. ● President, CEO, Treasurer and Director of Bio-Vascular, Inc. </li></ul></ul><ul><li>Dr. Peter Morawetz </li></ul><ul><ul><li>Director of BioDrain since inception ● Consulting experience with notable corporation including: Medtronic, EMPI, Hutchinson Technologies, Minntech, Bauer Biopsy Needles, American Medical, Lectec and Walker Reading Technologies </li></ul></ul><ul><li>Tom McGoldrick </li></ul><ul><ul><li>CEO of Monteris Medical Inc. ● CEO of Fastitch Surgical ● President and CEO of Minntech ● Senior marketing, business development and international positions at Medtronic, Cardiac Pacemakers, Inc. and Johnson & Johnson </li></ul></ul><ul><li>Andy Reding </li></ul><ul><ul><li>President and CEO of TRUMPF Medical Systems, Inc. ● National sales leader Smith & Nephew Endoscopy ● Sales, marketing, and management, Berchtold Corporation ● Significant experience marketing products for the OR, ER and ICU </li></ul></ul><ul><li>Jim Dauwalter </li></ul><ul><ul><li>Former CEO and Chairman of Entegris, Inc., with broad functional background and experience including sales & marketing, operational, and financial experiences. </li></ul></ul>
    16. 16. Key Points for Investment <ul><li>Addresses real customer needs – safety and saves $$ </li></ul><ul><li>Market – established, large & growing, room for penetration </li></ul><ul><li>Product – differentiable </li></ul><ul><li>Intellectual Property – strong and secured </li></ul><ul><li>Management – experienced, proven liquidity events </li></ul><ul><li>Low investment / near term results (already in market) </li></ul><ul><li>Business model – razor / razor blade </li></ul><ul><li>Attractive valuation </li></ul><ul><li>Addresses government regulations </li></ul><ul><li>Provides “Green” solution </li></ul>
    17. 17. Investment Opportunity <ul><li>$500,000 bridge round </li></ul><ul><li>$.50 per unit </li></ul><ul><li> Unit = 1 share common + warrant to purchase 1 share common at $.65 </li></ul><ul><li>$25,000 minimum </li></ul><ul><li>$5.0 million pre-money valuation </li></ul><ul><li>  </li></ul><ul><li>Use of funds: </li></ul><ul><ul><ul><ul><ul><li>Manufacturing $150,000 </li></ul></ul></ul></ul></ul><ul><ul><ul><ul><ul><li>Market Expansion $150,000 </li></ul></ul></ul></ul></ul><ul><ul><ul><ul><ul><li>Working Capital $100,000 </li></ul></ul></ul></ul></ul><ul><ul><ul><ul><ul><li>Product Development $25,000 </li></ul></ul></ul></ul></ul><ul><ul><ul><ul><ul><li>Legal $25,000 </li></ul></ul></ul></ul></ul><ul><ul><ul><ul><ul><li>Expenses $50,000 </li></ul></ul></ul></ul></ul>
    18. 18. Join the New Movement <ul><li>Safer </li></ul><ul><li>Less Costly </li></ul><ul><li>More Efficient </li></ul><ul><li>Regulatory Compliant </li></ul><ul><li>Environmentally Friendly </li></ul><ul><li>  </li></ul>
    19. 19. Kevin Davidson President & CEO